---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-217296"
form_type: "8-K"
ticker: "RLAY"
cik: "0001812364"
company_name: "Relay Therapeutics, Inc."
filed_at: "2024-09-11T23:59:59+00:00"
generated_at: "2026-05-31T05:28:42.056915+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Relay Therapeutics prices $200M public offering of common stock at $7.00/share

## Summary
- Public offering of 28.57M shares at $7.00/share; gross proceeds ~$200M.
- Net proceeds estimated at ~$189.5M after underwriting discounts and expenses.
- Underwriters granted 30-day option to purchase up to an additional 4.29M shares.
- Offering expected to close on September 12, 2024; lead managers include Goldman Sachs, TD Cowen, Stifel, BofA Securities.
- All shares sold by the company; proceeds will support clinical-stage precision medicine programs.

## SEC filing metadata
- accession: 0001193125-24-217296
- form_type: 8-K
- ticker: RLAY
- cik: 0001812364
- company_name: Relay Therapeutics, Inc.
- filed_at: 2024-09-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1812364/000119312524217296/0001193125-24-217296-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1812364/000119312524217296/d892276d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-217296
- JSON: https://secwatch.observer/filing/0001193125-24-217296.json
- Plain text: https://secwatch.observer/filing/0001193125-24-217296.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.